Knowledge about CsA metabolites is critical to our understanding and application of therapeutic drug monitoring to guide most-effective dosing of CsA in continuing efforts to minimize the risks of side effects while maximizing the opportunity for immunosuppression (1) (2) (3) . This controversial issue has been the subject of many studies published in this and other journals and a topic of keen interest to many in the transplant field. Clin Chem. To be published. 6. Bowers LD, Wilson PD, Vine W. Nephrotoxicity of cyclosporine metabolites. To be published.

